Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Miller

Showing results (1-10 of 325) with videos related to

Pageof 33
Sort By:
Blood|July 9, 2008
How killers killJeffrey S Miller
Cytotherapy|April 7, 2009
Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential?Jeffrey S Miller
Hematology. American Society of Hematology. Education Program|December 10, 2013
Therapeutic applications: natural killer cells in the clinicJeffrey S Miller
Cancer Investigation|May 25, 2002
Biology of natural killer cells in cancer and infectionJeffrey S Miller
Haematologica|August 28, 2015
ADAM17 and CD56low CD16low NK cellsRizwan Romee, Jeffrey S Miller
Cancer Immunology Research|September 8, 2021
Putting On the Gas and Taking Off the Brakes: A Novel Combinatorial Strategy to Enhance Tumor-Infiltrating LymphocytesMartin Felices, Jeffrey S Miller
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2009
In vitro development of human Killer-Immunoglobulin Receptor-positive NK cellsFrank Cichocki, Jeffrey S Miller
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Assessing Canonical and Adaptive Natural Killer Cell Function in Suppression Assays In VitroDhifaf Sarhan, Jeffrey S Miller
Blood|March 5, 2016
NK cells pave the road for alloengraftmentMartin Felices, Jeffrey S Miller
Cell Research|July 12, 2022
Promoting T and NK cell attack: preserving tumor MICA/B by vaccinesFrank Cichocki, Jeffrey S Miller
Pageof 33

Showing results (1-10 of 325) with videos related to

Sort By:
Pageof 33
Blood|July 9, 2008
How killers killJeffrey S Miller
Cytotherapy|April 7, 2009
Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential?Jeffrey S Miller
Hematology. American Society of Hematology. Education Program|December 10, 2013
Therapeutic applications: natural killer cells in the clinicJeffrey S Miller
Cancer Investigation|May 25, 2002
Biology of natural killer cells in cancer and infectionJeffrey S Miller
Haematologica|August 28, 2015
ADAM17 and CD56low CD16low NK cellsRizwan Romee, Jeffrey S Miller
Cancer Immunology Research|September 8, 2021
Putting On the Gas and Taking Off the Brakes: A Novel Combinatorial Strategy to Enhance Tumor-Infiltrating LymphocytesMartin Felices, Jeffrey S Miller
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2009
In vitro development of human Killer-Immunoglobulin Receptor-positive NK cellsFrank Cichocki, Jeffrey S Miller
Methods in Molecular Biology (Clifton, N.J.)|January 23, 2019
Assessing Canonical and Adaptive Natural Killer Cell Function in Suppression Assays In VitroDhifaf Sarhan, Jeffrey S Miller
Blood|March 5, 2016
NK cells pave the road for alloengraftmentMartin Felices, Jeffrey S Miller
Cell Research|July 12, 2022
Promoting T and NK cell attack: preserving tumor MICA/B by vaccinesFrank Cichocki, Jeffrey S Miller
Pageof 33